Granules India Limited, in collaboration with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, has officially opened the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical
Pharmaceutical company Lupin Ltd today announced that the US Food and Drug Administration (USFDA), granted approval on its generic risperidone LAI extended-release injectable suspension (25 mg, 37.5 mg, and 50 mg single-dose vials) for the...
.jpeg "Novo Nordisk to End rDNA Insulin Product Sales in India")
Novo Nordisk India’s proposal to discontinue several recombinant DNA (rDNA) origin insulin products from the Indian market has been approved by the Subject Expert Committee
Servier, an independent global pharmaceutical organization governed by a foundation, along with IDEAYA Biosciences, Inc., a prominent precision medicine oncology firm, have declared an exclusive licensing agreement aimed at making darovasertib
Caplin Point Laboratories Ltd revealed today that its subsidiary Caplin Steriles Ltd has received final approval from the United States Food and Drug Administration (USFDA) for its generic Milrinone Lactate in 5% Dextrose Injection. Milrinone is...
The highly-anticipated India MedTech Expo 2025 was inaugurated this morning at Bharat Mandapam, Pragati Maidan, by Union Minister for Health & Family Welfare and Chemicals & Fertilizers, Jagat Prakash Nadda, with Union Minister of State for...
As part of the uniform code for marketing practices, manufacturers of medical devices are allowed to give doctors free evaluation samples so they can get firsthand experience using the product
The Maharashtra Food and Drug Administration (FDA) has made substantial improvements to its testing facilities to address the continued high demand for drug regulation and quality testing. The FDA’s laboratories in Mumbai and Aurangabad have...
The plan by healthcare giant Manipal Hospitals to buy Pune-based Sahyadri Hospitals from international investor Ontario Teachers' Pension Plan Board in a deal valued at around Rs. 6,400 crore has been approved by the Competition Commission of India
Future presentations at the Ophthalmology Futures Retina Forum, the EURETINA Innovation Spotlight (EIS), the 25th European Society of Retina Specialists (EURETINA) Congress, and the Retina Society Annual Congress have been announced by
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")